| Product Code: ETC10939573 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Latvia`s vaccine import market continues to be dominated by key players such as Metropolitan France, Germany, Lithuania, Poland, and the USA. Despite a high concentration with a Herfindahl-Hirschman Index (HHI) remaining very high, the market has shown significant growth with a compound annual growth rate (CAGR) of 43.42% from 2020 to 2024. However, there was a notable decline in growth rate from 2023 to 2024 at -57.01%, indicating potential shifts in the market dynamics. This data suggests a dynamic landscape in the vaccine import market in Latvia, with opportunities for further exploration and analysis.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Vaccine Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Vaccine Market - Industry Life Cycle |
3.4 Latvia Vaccine Market - Porter's Five Forces |
3.5 Latvia Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Latvia Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Latvia Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Latvia Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Latvia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government focus on vaccination programs to improve public health |
4.2.2 Growing awareness about the importance of vaccination in preventing diseases |
4.2.3 Rise in infectious diseases and outbreaks driving the demand for vaccines |
4.3 Market Restraints |
4.3.1 Limited access to advanced vaccines due to cost constraints |
4.3.2 Vaccine hesitancy among certain population groups impacting vaccination rates |
4.3.3 Regulatory challenges and approval processes delaying the introduction of new vaccines |
5 Latvia Vaccine Market Trends |
6 Latvia Vaccine Market, By Types |
6.1 Latvia Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Latvia Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Latvia Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Latvia Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Latvia Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Latvia Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Latvia Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Latvia Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Latvia Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Latvia Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Latvia Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Latvia Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Latvia Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Latvia Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Latvia Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Latvia Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Latvia Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Latvia Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Latvia Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Latvia Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Latvia Vaccine Market Import-Export Trade Statistics |
7.1 Latvia Vaccine Market Export to Major Countries |
7.2 Latvia Vaccine Market Imports from Major Countries |
8 Latvia Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rates among different age groups |
8.2 Number of government-funded vaccination campaigns conducted annually |
8.3 Research and development investment in new vaccine technologies and formulations |
8.4 Rate of vaccine uptake in high-risk populations |
8.5 Number of reported cases of vaccine-preventable diseases |
9 Latvia Vaccine Market - Opportunity Assessment |
9.1 Latvia Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Latvia Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Latvia Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Latvia Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Latvia Vaccine Market - Competitive Landscape |
10.1 Latvia Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Latvia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here